CBAN同业对比
CBAN 与SIC 6022 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CBAN本股 | $461M#8 | 55.8x#15 | 1.2x#9 | — | — | -72.3%#16 | — | 1.7%#14 | 8.2%#8 | — | — | 1.7%#12 |
| OBT | $504M#2 | 11.0x#6 | 1.7x#14 | — | — | 49.2%#4 | — | 14.3%#2 | — | — | — | 1.4%#13 |
| COFS | $501M#3 | 7.9x#1 | 1.1x#5 | 2.2x#1 | 63.6%#1 | 5.4%#13 | 29.6%#4 | 6.0%#12 | — | — | — | 3.4%#4 |
| BSVN | $481M#4 | 10.8x#5 | 1.9x#16 | — | — | -5.8%#14 | — | 16.6%#1 | — | — | — | 1.9%#11 |
| CWBC | $676M#1 | 11.5x#8 | 1.6x#12 | — | — | 397.9%#2 | — | 9.1%#8 | 12.4%#7 | — | — | 1.4%#14 |
| WTBA | $475M#5 | 12.4x#10 | 1.7x#13 | — | — | 35.4%#7 | — | 11.6%#5 | 33.9%#1 | — | — | 3.6%#2 |
| BMRC | $468M#6 | — | 1.2x#7 | — | — | 82.3%#3 | — | 6.7%#10 | — | — | — | 3.4%#3 |
| CBK | $466M#7 | 11.6x#9 | 1.6x#11 | — | — | 18.4%#10 | — | 12.7%#3 | 15.3%#6 | — | — | 0.4%#16 |
| CZNC | $456M#9 | 15.1x#14 | 1.4x#10 | — | — | -9.8%#15 | — | 7.0%#9 | 15.4%#5 | — | 40.4%#2 | 3.6%#1 |
| RBB | $446M#10 | 11.2x#7 | 0.9x#1 | 86.3x#2 | -2.4%#4 | 19.8%#9 | 2786.9%#2 | 6.1%#11 | 24.5%#2 | — | 49.2%#1 | 2.5%#6 |
| ISTR | $415M#11 | 13.3x#11 | 1.0x#4 | — | — | 13.1%#11 | — | 5.5%#13 | 18.0%#4 | — | — | 1.0%#15 |
| PKBK | $398M#13 | 9.7x#3 | 1.2x#8 | — | — | 37.3%#6 | — | 11.3%#6 | — | — | — | 2.1%#9 |
| USCB | $400M#12 | 15.0x#13 | 1.8x#15 | — | — | 5.8%#12 | — | 11.7%#4 | — | — | — | 2.0%#10 |
| PCB | $394M#14 | 9.9x#4 | 1.0x#3 | 136.0x#4 | 4.5%#3 | 45.1%#5 | 3972.4%#1 | 9.4%#7 | — | — | — | 2.9%#5 |
| FRST | $394M#15 | 8.5x#2 | 0.9x#2 | — | — | 479.2%#1 | — | 0.0%#15 | — | — | — | 2.5%#7 |
| MVBF | $393M#16 | 14.0x#12 | 1.2x#6 | 115.5x#3 | 51.9%#2 | 33.0%#8 | 2249.7%#3 | 0.0%#16 | 20.7%#3 | — | — | 2.2%#8 |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-01。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议